EVOKE PHARMA INC (EVOK) Stock Earnings Estimates
NASDAQ:EVOK • US30049G3020
11 USD
+0.04 (+0.36%)
Last: Dec 16, 2025, 08:19 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.51M 54.94% | 5.181M 106.40% | 10.249M 97.84% | 16.292M 58.96% | 25.74M 57.99% | 36.321M 41.11% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.79M 4.42% | -7.431M 4.61% | -5.204M 29.97% | -4.922M 5.43% | 2.156M 143.81% | 10.126M 369.67% | |
| Operating Margin | -310.36% | -143.44% | -50.77% | -30.21% | 8.38% | 27.88% | |
| EPS YoY % growth | -32.16 17.28% | -27.96 13.06% | -4.54 83.76% | -1.92 57.76% | 0.69 136.17% | 2.09 201.47% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.31 51.43% |
| Revenue Q2Q % growth | 4.954M 49.71% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -843.54K 29.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.45 52.13% | -0.46 | 0.01 | 1.96% |
| Q2 2025 Q2Q % growth | -0.62 33.33% | -0.31 | -0.31 | -102.61% |
| Q1 2025 Q2Q % growth | -0.51 75.00% | -0.34 | -0.17 | -51.52% |
| Q4 2024 Q2Q % growth | -0.63 91.10% | -0.64 | 0.01 | 1.96% |
| Q3 2024 Q2Q % growth | -0.94 84.64% | -0.39 | -0.55 | -142.52% |
| Q2 2024 Q2Q % growth | -0.93 86.16% | -0.73 | -0.20 | -26.63% |
| Q1 2024 Q2Q % growth | -2.04 74.63% | -2.57 | 0.53 | 20.63% |
| Q4 2023 Q2Q % growth | -7.08 -11.32% | -6.12 | -0.96 | -15.69% |
| Q3 2023 Q2Q % growth | -6.12 15.00% | -7.59 | 1.47 | 19.35% |
| Q2 2023 Q2Q % growth | -6.72 21.13% | -8.94 | 2.22 | 24.79% |
| Q1 2023 Q2Q % growth | -8.04 20.24% | -7.10 | -0.94 | -13.25% |
| Q4 2022 Q2Q % growth | -6.36 26.39% | -6.49 | 0.13 | 1.96% |
| Q3 2022 Q2Q % growth | -7.20 16.67% | -8.08 | 0.88 | 10.87% |
| Q2 2022 Q2Q % growth | -8.52 15.48% | -7.34 | -1.18 | -16.01% |
| Q1 2022 Q2Q % growth | -10.08 12.50% | -5.88 | -4.20 | -71.57% |
| Q4 2021 Q2Q % growth | -8.64 33.33% | -11.75 | 3.11 | 26.47% |
| Q3 2021 Q2Q % growth | -8.64 25.00% | -10.28 | 1.64 | 15.97% |
| Q2 2021 Q2Q % growth | -10.08 75.00% | -11.75 | 1.67 | 14.22% |
| Q1 2021 Q2Q % growth | -11.52 -14.29% | -9.55 | -1.97 | -20.66% |
| Q4 2020 Q2Q % growth | -12.96 | -19.83 | 6.87 | 34.64% |
| Q3 2020 Q2Q % growth | -11.52 | -12.48 | 0.96 | 7.73% |
| Q2 2020 Q2Q % growth | -40.32 | -11.75 | -28.57 | -243.14% |
| Q1 2020 Q2Q % growth | -10.08 | -7.34 | -2.74 | -37.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 4.284M 61.42% | 4.413M | -129.02K | -2.92% |
| Q2 2025 Q2Q % growth | 3.752M 47.08% | 3.872M | -120K | -3.10% |
| Q1 2025 Q2Q % growth | 3.08M 77.47% | 3.382M | -302K | -8.93% |
| Q4 2024 Q2Q % growth | 3.309M 97.44% | 3.146M | 163K | 5.18% |
| Q3 2024 Q2Q % growth | 2.654M 69.82% | 3.425M | -771K | -22.51% |
| Q2 2024 Q2Q % growth | 2.551M 125.55% | 3.04M | -489K | -16.09% |
| Q1 2024 Q2Q % growth | 1.735M 114.26% | 2.181M | -445.51K | -20.43% |
| Q4 2023 Q2Q % growth | 1.676M 109.50% | 1.665M | 10.99K | 0.66% |
| Q3 2023 Q2Q % growth | 1.563M 88.30% | 1.288M | 274.86K | 21.34% |
| Q2 2023 Q2Q % growth | 1.131M 145.87% | 1.118M | 13K | 1.16% |
| Q1 2023 Q2Q % growth | 810K 92.86% | 1.023M | -213K | -20.82% |
| Q4 2022 Q2Q % growth | 800K 122.22% | 906.78K | -106.78K | -11.78% |
| Q3 2022 Q2Q % growth | 830K -10.75% | 583.44K | 246.56K | 42.26% |
| Q2 2022 Q2Q % growth | 460K 91.67% | 591.6K | -131.6K | -22.24% |
| Q1 2022 Q2Q % growth | 420K 366.67% | 545.7K | -125.7K | -23.03% |
| Q4 2021 Q2Q % growth | 360K 1,700.00% | 517.14K | -157.14K | -30.39% |
| Q3 2021 Q2Q % growth | 930K | 389.64K | 540.36K | 138.68% |
| Q2 2021 Q2Q % growth | 240K | 154.02K | 85.98K | 55.82% |
| Q1 2021 Q2Q % growth | 90K | 849.66K | -759.66K | -89.41% |
| Q4 2020 Q2Q % growth | 20K | 861.9K | -841.9K | -97.68% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 23.08% | 4.08% | 4.08% |
| Revenue | 0% | 4.29% | 1% | 1% |